Regular coffee consumption linked to lower risk of liver disease and cancer

A large long‑term study of more than 354,000 adults followed for over a decade found that daily coffee drinking is associated with a reduced risk of serious liver conditions. Participants who drank one to two cups a day had about a 20 % lower chance of cirrhosis and a 24 % lower chance of liver cancer. Those who consumed three to four cups saw risk reductions of roughly 35 %, while five or more cups were linked to up to a 47 % lower risk of liver cancer and a 42 % lower probability of liver‑related death. The protective effect was observed with both caffeinated and decaffeinated coffee, suggesting that antioxidants and other bioactive compounds, rather than caffeine, drive the benefit. Researchers warned that coffee is not a substitute for a healthy lifestyle, emphasizing the importance of balanced diet, regular exercise, moderate alcohol intake and maintaining a healthy weight. “Probablemente, estos sean los datos de seguimiento a largo plazo más completos sobre el impacto del café,” said Dr Hyunseok Kim, one of the study’s authors.

The findings were published in Clinical Gastroenterology and Hepatology and reported in multiple media outlets across Europe, the Americas and the Middle East.